Our website uses cookies to enhance your browsing experience and to collect information about how you use this site to improve our service to you. By not accepting cookies some elements of the site, such as video, will not work. Please visit our Cookie Policy page for more information on how we use cookies.

News & Events

Exertis Supply Chain Services opens state-of-the-art GMP controlled biopharma facility in Limerick

To provide logistical support to US biopharmaceutical FDI

Exertis Supply Chain Services (ESCS), a Dublin-based subsidiary of DCC plc, has announced the official opening of its new 100,000 square foot GMP (Good Manufacturing Practice) controlled logistics facility in Raheen, Limerick. The announcement was made during the Trade Mission in Ireland organised by Enterprise Ireland and IDA Ireland and led by the Minister for Jobs, Enterprise and Innovation, Mary Mitchell O’Connor TD. 

In the past year, ESCS has transformed this under-utilised site into one of the largest GMP controlled biopharmaceutical warehousing facilities in Ireland. 

ESCS is now working with a large new US biopharmaceutical FDI, providing warehousing and transport services for its purpose built factory in the mid-west of Ireland, which will be the largest capacity biopharmaceutical production facility in Ireland. 

The GMP warehouse will provide ESCS with the capacity to assist domestic as well as international biopharmaceutical companies in need of supply chain support. With the project generating twelve direct and eight indirect new jobs thus far, it is expected that the new facility will continue to yield wider societal and economic benefits, as new employment opportunities arise and local businesses capture value from the activities of foreign direct investment in the region.                                                        

Opening the new facility, Minister for Jobs, Enterprise and Innovation, Mary Mitchell O’Connor said: “I am delighted to open this new state-of-the-art logistics facility in Raheen, Limerick. The operations of Exertis Supply Chain Services will add significant knock on benefits to the region. This is great news for Limerick and the mid-west region, and is also a great example of the strong links that exist between indigenous Irish companies and global multinational companies based here. From a state support perspective it demonstrates the effectiveness of IDA and Enterprise Ireland collaboration and cooperation through the Global Sourcing initiative. I warmly congratulate Exertis Supply Chain Services and wish them continued success for the future”.

Neal Johnston, Managing Director, Exertis Supply Chain Services said: “Exertis, as a leading indigenous supply chain partner, enables foreign direct investment, by providing swift and effective support for their start-up operations, both in Ireland and overseas.”

ENDS

Photos will be syndicated by Keith Wiseman Photography.

For further information and interview opportunities, please contact:

Stephen Davis, Marketing Manager, Exertis Supply Chain Services +353 1 405 6586 l stephen.davis@exertis.com

Notes to the Editor:

About Exertis & Exertis Supply Chain Services (ESCS)

Exertis is the “Technology” division of DCC plc (www.dcc.ie), and is a leading technology sales, marketing, distribution and supply chain services business. Exertis has operations in UK, Ireland, France, Sweden, Germany, Netherlands, Belgium, Dubai, Spain, China, Poland, and the United States. It has annual revenues of €3.3 billion and employs over 2,000 people. Headquartered in Dublin and operating internationally, Exertis’ supply chain services business (ESCS) provides materials supply chain services across sectors, including pharma, and is the largest indigenous materials supply chain management company in Ireland. The business employs over 160 people in five countries.

About DCC plc

DCC plc is an international sales, marketing, distribution and business support services group headquartered in Dublin with operations principally in Britain, Continental Europe and Ireland. DCC has four divisions - DCC Energy, DCC Healthcare, DCC Technology (“Exertis”) and DCC Environmental. In its last financial year ended 31 March 2016, DCC generated revenue of £10.6 billion and operating profit of £301 million and currently employs over 11,000 people in 15 countries. DCC's shares are listed on the London Stock Exchange and are included in the FTSE 100 Index. 

–      ENDS –